Kanda K, Waki S, Uchimura M, Kida H, Narita K, Harada N
Dept. of Surgery, Hamamatsu Medical Center.
Gan To Kagaku Ryoho. 1990 Dec;17(12):2421-4.
A 34-year-old female patient with breast cancer metastasizing to bone had a remission after a course of treatment with medroxyprogesterone acetate (MPA) 1,200 mg/day, but again had a metastasis to the lungs. The patient was then instituted on a combination therapy with UFT 400 mg/day, and MPA 1,200 mg/day. As a result, the pulmonary metastasis disappeared, along with the consolidation of the bone involved.
一名34岁的乳腺癌骨转移女性患者，在接受每日1200毫克醋酸甲羟孕酮（MPA）的一个疗程治疗后病情缓解，但后来肺部又出现转移。随后该患者开始接受每日400毫克优福定（UFT）与每日1200毫克MPA的联合治疗。结果，肺部转移灶消失，同时受累骨骼的骨质也得以巩固。
